FDA Adverse Event Injury Summary report: N

PROMUS EVEROLIMUS ELUTING CORONARY STENT SYSTEM

MDR report key: 1884711 · Received October 25, 2010

Report

Report Number
2024168-2010-02248
Event Type
Injury
Date Received
October 25, 2010
Date of Event
August 1, 2010
Report Date
September 30, 2010
Manufacturer
ABBOTT VASCULAR-CARDIAC THERAPIES
Product Code
NIQ
PMA / PMN Number
P070015
Removal / Correction Number
NA
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
TN, US
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

(B)(4). THE STENT REMAINS IN THE PT. THROMBOSIS IS A KNOWN ADVERSE EVENT AS LISTED IN THE PROMUS INSTRUCTIONS FOR USE. ALTHOUGH A CONCLUSIVE CAUSE FOR THE REPORTED PT EFFECTS AND THE RELATIONSHIP TO THE DEVICE, IF ANY, COULD NOT BE DETERMINED, THERE IS NO INDICATION OF A PRODUCT QUALITY DEFICIENCY WITH RESPECT TO MANUFACTURE, DESIGN OR LABELING. ALL STENT DELIVERY SYSTEMS ARE SUBJECTED TO A 100% VISUAL INSPECTION. IN ADDITION, A QUALITY CONTROL AUDIT INSPECTION IS USED TO VERIFY THE PRODUCT QUALITY.

Description of Event or Problem · 1

IT WAS REPORTED THAT ON (B)(6) 2009, A PROMUS 2.5 X 28 STENT WAS SUCCESSFULLY IMPLANTED IN THE PROXIMAL TO MID SEGMENT OF THE DIAGONAL BRANCH AFTER PRE-DILATATION. ON (B)(6) 2010, THE PT PRESENTED WITH SEVERE CHEST PAIN. ON (B)(6) 2010, THROMBECTOMY OF THE PROMUS STENT WAS PERFORMED FOLLOWED BY DEPLOYMENT OF A VISION STENT. ANGIOGRAM SHOWED EXCELLENT RESULTS. THERE WAS NO REPORTED ADVERSE PT SEQUELA. REPORTEDLY, THE PT HAD RECENTLY BEEN TAKEN OFF ASPIRIN, PLAVIX, AND COUMADIN IN PREPARATION FOR EYE SURGERY. THOUGH REQUESTED, ADDITIONAL INFO WAS NOT PROVIDED. YOU ARE RECEIVING THIS MDR REPORT FROM ABBOTT VASCULAR BECAUSE BOSTON SCIENTIFIC CORPORATION DISTRIBUTES PROMUS AS ITS OWN BRAND LABELING OF ABBOTT VASCULAR'S DRUG ELUTING STENT IN THE US.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 PROMUS EVEROLIMUS ELUTING CORONARY STENT SYSTEM NIQ ABBOTT VASCULAR-CARDIAC THERAPIES NA 8121741

Patients

Seq Age Sex Outcome Treatment
1 61 YR Hospitalization| R DIL CATH: APEX 2.0X20| 6 FR ANGIOSEAL| QUANTUM MAVERICK 3.5X15| WHISPER GUIDE WIRE| VOYAGER 2.0X15